Recently, the American College of Gastroenterology (ACG) and the Society for the End of Obesity (CEO) joined forces to highlight the potentially deadly link between body mass index (BMI) and colorectal cancer. Considering the increasing rate of obesity in the United States and the various scientific studies showing that obesity increases the risk of colorectal cancer, the two organizations joined forces for March – Colorectal Cancer Awareness Month. The goal is to bring awareness to the fact that the second leading killer of cancer in the United States today, colorectal cancer, has obesity as a major risk factor! And to bring awareness to the fact that colorectal cancer screening is quite important for people with a high BMI. ”Dietary and other controllable risk factors can explain up to 90 percent of colorectal cancer patients, and recent studies have shown that nearly a quarter of those with colorectal cancer could have been prevented from developing the disease by a good lifestyle habit.” Lawrence R. Schiller, MD, FACG, president of the ACG Association, explained to us, “Consumers need to understand that a high BMI may increase the risk of colorectal cancer, so people should take this risk seriously and actively communicate with their physicians for colorectal cancer screening. “ CEO co-founder, Stephanie Silverman, told us, “Obesity is a dangerous precursor to a host of serious diseases, including colorectal cancer. Two-thirds of adults are currently struggling with overweight and obesity because people are beginning to understand and plan for their long-term health. And thankfully, there are many useful and practical tools available to help people. One of the most effective and easy to implement is screening, which can help prevent colorectal cancer and obesity. Of course, awareness and education about these issues is of the utmost importance.” The association between metabolic syndrome and colorectal cancer mortality and the higher risk of colorectal cancer in type 2 diabetes suggest that insulin resistance and hyperinsulinemia due to obesity may be involved in the development of colorectal cancer. Based on this and the epidemiological findings, the ACG and CEO took a firm stand and decided to provide the community, families, educators and decision makers with the most up-to-date information, teaching tools and resources to empower them to make the most current decisions when it comes to standard weight and colorectal cancer control measures.